ArticleThe oncologist2022

TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.

Jack V W Bacon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.